サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1206507

中東・アフリカの左心室補助装置市場の2028年までの予測- 地域別分析- フローの種類別、デザイン別、用途別

Middle East & Africa Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Type of Flow, Design, and Application
出版日: | 発行: The Insight Partners | ページ情報: 英文 94 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
中東・アフリカの左心室補助装置市場の2028年までの予測- 地域別分析- フローの種類別、デザイン別、用途別
出版日: 2023年01月24日
発行: The Insight Partners
ページ情報: 英文 94 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中東・アフリカの左心室補助装置市場は、2022年の7,056万米ドルから2028年には8,886万米ドルに成長すると予測されています。2022年から2028年までのCAGRは3.9%と推定されています。

LVADにおける人工知能と機械学習の使用の増加が中東・アフリカの左心室補助装置市場の成長を促進する

LVADに関連する合併症や有害事象の発生率が高まることで、メーカーは革新的な技術を開発し、新しい技術を機器に組み込むよう促しています。LVADを装着した患者が右心室不全に陥り、静脈に血液が溜まって腫れるケースがいくつかあります。この失敗を減らすために、メーカーはLVADに人工知能（AI）を組み込んで右心室を監視しています。これにより、右心室の活動や機能に変化があれば、医療従事者に報告され、右心室の故障や合併症の可能性を低減することができます。さらに、心不全の死亡率を示すリスクスコアの開発に機械学習（ML）を活用することで、従来の方法よりも優位に立つことができます。さらに、ウェアラブルデバイスからのテレメトリデータ解析は、心不全による入院の予測に役立ちます。したがって、人工知能と機械学習アルゴリズムの使用は、LVADを装着した末期心不全患者の右心室機能に基づくリスク予測モデルの開発に役立ちます。右室不全のリスク層別化は、患者の生存を左右する重要な要因の一つです。したがって、LVADにおける人工知能と機械学習の統合は、予測期間中に中東・アフリカの左心室補助装置市場における主要な動向として浮上する可能性があります。

中東＆アフリカの左心室補助装置市場の概要

中東＆アフリカの左心室補助装置市場は、UAE、サウジアラビア、南アフリカ、その他中東＆アフリカに区分されます。サウジアラビアは予測期間中に最大の市場シェアを占めると予想されます。南アフリカの市場は、予測期間中に最も高いCAGRで成長すると予想されています。中東・アフリカの市場成長は、心血管障害患者の有病率の上昇、心不全の発生率の増加、心臓移植の待機期間の長さ、ヘルスケアインフラの整備などの要因に起因しています。また、同地域における医療観光の増加や可処分所得の急増により、今後数年間はLVADの需要が見込まれます。さらに、複数の民間機関によるヘルスケア分野への投資の増加や、新興国市場との病院連携の増加も、予測期間中に中東・アフリカの左心室補助装置市場をさらに押し上げると予想されています。

中東・アフリカの左心室補助装置市場の収益と2028年までの予測（金額）

中東＆アフリカの左心室補助装置市場のセグメンテーション

中東・アフリカの左心室補助装置市場は、流れの種類、デザイン、用途、国別に区分されます。

左心室補助循環装置市場は、流れの種類によって非脈動性と脈動性に分類されます。2022年には、非脈動性セグメントが最大の市場シェアを記録しました。

設計に基づいて、中東＆アフリカの左心室補助装置市場は、植え込み型心室補助装置と経皮心室補助装置に二分されます。2022年には植え込み型補助人工心臓が最も大きな市場シェアを獲得しました。

用途別に見ると、中東・アフリカの左心室補助装置市場は、目的地治療、移植への橋渡し、候補地への橋渡し、回復への橋渡しに区分されます。2022年の市場シェアは、目的地治療が最も高いです。

中東・アフリカの左心室補助装置市場は、国別に、サウジアラビア、南アフリカ、UAE、その他中東・アフリカに区分されます。2022年はサウジアラビアが市場を席巻しています。

ABIOMED Inc、Abbott Laboratories、Medtronic Plc、LivaNova Plc、およびEvaheart Incは、中東＆アフリカの左心室補助装置市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 中東・アフリカの左心室補助装置市場- 市場展望

  • PEST分析
  • 専門家の見解

第5章 中東・アフリカの左心室補助装置市場- 主要な市場力学

  • 市場促進要因
    • 対象疾患と手術の発生率の上昇
  • 市場抑制要因
    • 左心室補助装置に関連する製品回収と合併症の増加
  • 市場機会
    • 新興国における未開発のポテンシャル
  • 今後の動向
    • LVADにおける人工知能と機械学習の利用拡大
  • 影響度分析

第6章 中東・アフリカの左心室補助装置市場分析

  • 中東・アフリカの左心室補助装置市場の収益と予測・分析

第7章 中東・アフリカの左心室補助装置の市場分析- フローの種類別

  • 中東・アフリカの左心室補助装置市場：フローの種類別2021年・2028年（%）
  • 拍動性フロー
  • 非拍動性の概要

第8章 中東・アフリカの左心室補助装置の市場分析- デザイン別

  • 中東・アフリカの左心室補助装置市場：デザイン別2021年・2028年（%）
  • 植込み型心室アシストデバイス
  • 経皮的心室アシストデバイス

第9章 中東・アフリカの左心室補助装置市場分析- 用途別

  • 中東・アフリカの左心室補助装置市場：用途別2021年・2028年（%）
  • 移植への橋渡し
  • デスティネーションセラピー
  • 回復への橋渡し
  • 候補への橋渡し

第10章 中東・アフリカの左心室補助装置市場- 国別分析

    • 中東・アフリカ地域
      • UAE（アラブ首長国連邦）
      • サウジアラビア
      • 南アフリカ共和国
      • 中東・アフリカのその他の地域

第11章 企業プロファイル

  • ABIOMED Inc
  • Abbott Laboratories
  • Medtronic Plc
  • LivaNova Plc
  • Terumo Corp

第12章 付録

図表

List Of Tables

  • Table 1. UAE Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. UAE Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. UAE Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Saudi Arabia Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Saudi Arabia Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Saudi Arabia Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. South Africa Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. South Africa Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. South Africa Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Rest of Middle East & Africa Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Rest of Middle East & Africa Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Rest of Middle East & Africa Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Glossary of Terms

List Of Figures

  • Figure 1. Middle East & Africa Left Ventricular Assist Device Market Segmentation
  • Figure 2. Middle East & Africa Left Ventricular Assist Device Market, By Country
  • Figure 3. Middle East & Africa Left Ventricular Assist Device Market Overview
  • Figure 4. Implantable Ventricular Assist Device Held Largest Share for Design Segment in Left Ventricular Assist Device Market
  • Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Middle East & Africa: PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. Impact Analysis
  • Figure 9. Middle East & Africa Left Ventricular Assist Device Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. Middle East & Africa Left Ventricular Assist Device Market, by Type of Flow 2021 & 2028 (%)
  • Figure 11. Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 12. Non-Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 13. Middle East & Africa Left Ventricular Assist Device Market, by Design 2021 & 2028 (%)
  • Figure 14. Implantable Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 15. Transcutaneous Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 16. Middle East & Africa Left Ventricular Assist Device Market, by Application 2021 & 2028 (%)
  • Figure 17. Bridge to Transplantation Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 18. Destination Therapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 19. Bridge to Recovery Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 20. Bridge to Candidacy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 21. Middle East & Africa: Left Ventricular Assist Device Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 22. UAE: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Saudi Arabia: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. South Africa: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Rest of Middle East & Africa: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00027940

The Middle East & Africa left ventricular assist device market in is expected to grow from US$ 70.56 million in 2022 to US$ 88.86 million by 2028. It is estimated to register a CAGR of 3.9% from 2022 to 2028.

Increasing Use of Artificial Intelligence and Machine Learning in LVAD is fueling the growth of Middle East & Africa Left Ventricular Assist Device Market

The increased incidence of complications and adverse events associated with LVAD encourages manufacturers to develop innovative technologies and integrate new technologies into the devices. In several cases, patients with LVAD devices experience right ventricle failure leading to blood buildup in veins and swelling. To reduce the failure, manufacturers have integrated artificial intelligence (AI) with LVAD to monitor the right ventricle. With this, any change in the right ventricle activity and function will be reported to the healthcare professional, reducing the chances of right ventricle failures and complications. Furthermore, the increased use of machine learning (ML) for developing risk scores indicating heart failure mortality provides an edge over conventional methods. Additionally, telemetry data analysis from wearable devices helps predict heart failure hospitalizations. Therefore, the use of artificial intelligence and machine learning algorithms helps develop a risk prediction model based on right ventricle functions in end-stage heart failure patients with LVAD. The risk stratification for right ventricle failure is one of the significant factors that help determine patients' survival. Therefore, the integration of artificial intelligence and machine learning in LVADs is likely to emerge as a key trend in the left ventricle assist device market in the Middle East & Africa during the forecast period.

Middle East & Africa Left Ventricular Assist Device Market Overview

The Middle East & Africa left ventricular assist devices market has been segmented into the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa. Saudi Arabia is expected to account for the largest market share during the forecast period. The market in South Africa is expected to grow at the highest CAGR during the forecast period. The market growth in the Middle East & Africa is attributed to factors such as a rise in the prevalence of cardiovascular disorder cases, an increase in the incidence of heart failure, the long waiting list for heart transplantation, and the development of healthcare infrastructure. Additionally, an increase in medical tourism in the region, followed by a surge in disposable income, is expected to create a demand for LVADs in the coming years. Moreover, rising investments in the healthcare sector from several private institutions and increasing collaboration of hospitals with developed regions are further expected to boost the Middle East & Africa left ventricular assist device market during the forecast period.

Middle East & Africa Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Left Ventricular Assist Device Market Segmentation

The Middle East & Africa left ventricular assist device market is segmented into type of flow, design, application, and country.

Based on type of flow, the Middle East & Africa left ventricular assist device market is segmented into non-pulsatile and pulsatile flow . The non-pulsatile segment registered the largest market share in 2022.

Based on design, the Middle East & Africa left ventricular assist device market is bifurcated into implantable ventricular assist devices and transcutaneous ventricular assist devices . The implantable ventricular assist devices segment registered the largest market share in 2022.

Based on application, the Middle East & Africa left ventricular assist device market is segmented into destination therapy, bridge to transplantation, bridge to candidacy, and bridge to recovery . The destination therapy segment registered the largest market share in 2022

The Middle East & Africa left ventricular assist device market, by country, is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

ABIOMED Inc; Abbott Laboratories; Medtronic Plc; LivaNova Plc; and Evaheart Inc are the leading companies operating in the Middle East & Africa left ventricular assist devices market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa left ventricular assist device market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa left ventricular assist device market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the left ventricular assist device market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Middle East & Africa Left Ventricular Assist Device Market - By Type of Flow
    • 1.3.2 Middle East & Africa Left Ventricular Assist Device Market - By Design
    • 1.3.3 Middle East & Africa Left Ventricular Assist Device Market - By Application
    • 1.3.4 Middle East & Africa Left Ventricular Assist Device Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa Left Ventricular Assist Device Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Experts Opinion

5. Middle East & Africa Left Ventricular Assist Device Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Elevating Incidence of Target Diseases and Procedures
  • 5.2 Market Restraints
    • 5.2.1 Growth in Product Recalls and Complications Associated with Left Ventricular Assist Devices
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Potential of Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Elevating Use of Artificial Intelligence and Machine Learning in LVAD
  • 5.5 Impact Analysis

6. Middle East & Africa Left Ventricular Assist Device Market Analysis

  • 6.1 Middle East & Africa Left Ventricular Assist Device Market Revenue Forecast & Analysis

7. Middle East & Africa Left Ventricular Assist Device Market Analysis - By Type of Flow

  • 7.1 Overview
  • 7.2 Middle East & Africa Left Ventricular Assist Device Market, By Type of Flow 2021 & 2028 (%)
  • 7.3 Pulsatile Flow
    • 7.3.1 Overview
    • 7.3.2 Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Non-Pulsatile Overview
    • 7.4.1 Non-Pulsatile Market Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Left Ventricular Assist Device Market Analysis - by Design

  • 8.1 Overview
  • 8.2 Middle East & Africa Left Ventricular Assist Device Market, By Design 2021 & 2028 (%)
  • 8.3 Implantable Ventricular Assist Devices
    • 8.3.1 Overview
    • 8.3.2 Implantable Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Transcutaneous Ventricular Assist Devices
    • 8.4.1 Overview
    • 8.4.2 Transcutaneous Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Left Ventricular Assist Device Market - By Application

  • 9.1 Overview
  • 9.2 Middle East & Africa Left Ventricular Assist Device Market, By Application 2021 & 2028 (%)
  • 9.3 Bridge to Transplantation
    • 9.3.1 Overview
    • 9.3.2 Bridge to Transplantation Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Destination Therapy
    • 9.4.1 Overview
    • 9.4.2 Destination Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Bridge to Recovery
    • 9.5.1 Overview
    • 9.5.2 Bridge to Recovery Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Bridge to Candidacy
    • 9.6.1 Overview
    • 9.6.2 Bridge to Candidacy Market Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Left Ventricular Assist Device Market - Country Analysis

  • 10.1 Overview
    • 10.1.1 Middle East & Africa: Left Ventricular Assist Device Market, by Country, 2022 & 2028 (%)
    • 10.1.2 Middle East & Africa: Left Ventricular Assist Device Market, by Country, 2021 & 2028 (%)
      • 10.1.2.1 The UAE: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 UAE: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 UAE: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.2.1.4 UAE: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.2.1.5 UAE Left Ventricular Assist Device Market, by Application, 2019-2028 (USD Million)
      • 10.1.2.2 Saudi Arabia: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Saudi Arabia: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Saudi Arabia: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.2.2.4 Saudi Arabia: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.2.2.5 Saudi Arabia Left Ventricular Assist Device Market, by Application, 2019-2028 (USD Million)
      • 10.1.2.3 South Africa: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 South Africa: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 South Africa: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.2.3.4 South Africa: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.2.3.5 South Africa Left Ventricular Assist Device Market, by Application, 2019-2028 (USD Million)
      • 10.1.2.4 Rest of Middle East & Africa: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Rest of Middle East & Africa: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.3 Rest of Middle East & Africa: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.2.4.4 Rest of Middle East & Africa: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.2.4.5 Rest of Middle East & Africa Left Ventricular Assist Device Market, by Application, 2019-2028 (USD Million)

11. Company Profiles

  • 11.1 ABIOMED Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Medtronic Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 LivaNova Plc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Terumo Corp
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms